SQUAMOUS CELL CARCINOMA OF HEAD AND NECK (SCCHN)
Clinical trials for SQUAMOUS CELL CARCINOMA OF HEAD AND NECK (SCCHN) explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CARCINOMA OF HEAD AND NECK (SCCHN) trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CARCINOMA OF HEAD AND NECK (SCCHN), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for hard-to-treat head and neck cancer: drug combo enters phase 2 trial
Disease control Not yet recruitingThis study tests whether adding ficerafusp alfa to the immunotherapy nivolumab can shrink tumors better than nivolumab alone in people with advanced head and neck cancer that has stopped responding to platinum chemotherapy. About 131 adults aged 18-75 will take part. The goal is …
Matched conditions: SQUAMOUS CELL CARCINOMA OF HEAD AND NECK (SCCHN)
Phase: PHASE2 • Sponsor: Groupe Oncologie Radiotherapie Tete et Cou • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Can a simple phone call after the ER get cancer patients treated faster?
Knowledge-focused Not yet recruitingThis pilot study will test whether trained community health navigators can help head and neck cancer patients get diagnosed and treated faster after an emergency room visit. The navigators will call or text patients to help with barriers like transportation, insurance, or housing…
Matched conditions: SQUAMOUS CELL CARCINOMA OF HEAD AND NECK (SCCHN)
Phase: NA • Sponsor: University of Tennessee • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC